Platelet-activating factor receptors

Pendino, K.J. et al., Induction of functionally active platelet activating factor receptors in rat alveolar macrophages, J. Biol. Chem., 268, 19165, 1993. 

Ramos, G., et al., Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression, Toxicol. Appl. Pharmacol., 195, 331, 2004. 

Barber, L. A. et al., Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line, J. Biol. Chem. 273, 18891-18897, 1998. 

Pei, Y. et al., Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis, J. Immunol. 161,1954—1961, 1998. 

Honda, Z.-I., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T., Shimizu, T. (1991). Cloning by functional expression of platelet-activating factor receptor from guinea pig lung. Nature 349, 342-6. 

Kobayashi K, Ishii S, Kume K, Takahashi T, Shimizu T, Manabe T. (1999). Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CAl region. Eur J Neurosci. 11(4) 1313-16. 

Fukunaga, K., Ishii, S., Asano, K., et al. (2001) Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. J. Biol. Chem. 276, 43025 3030. 

Parent, J. L., Le GouiU, C., Rola-Pleszczynski, M., and Stankova, J. (1996) Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production. Biochem. Biophys. Res. Commun. 219, 968-975. 

Honda Z., Ishii S., and Shimizu T. (2002). Platelet-activating factor receptor. J. Biochem. 131 773-779. 

Leitinger N., Watson A. D., Faull K. F., Fogelman A. M., and Berliner J. A. (1997). Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist. Adv. Exp. Med. Biol. 433 379-382. 

Shimizu,T., Honda, Z.,Nakamura, M., Bito,H., andI/.umi,T. (1992)Platelet-activating factor receptor and signal transduction, Biochem. Pharmacol. 44, 1001-1008. 

Hikiji H, Ishii S, Shindou H, Takato T, Shimizu T. Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy. J. Clin. Invest. 2004 114 85-93. 

Platelet-activating factor receptor antagonist Sm-I066l... 

Chau LY, Jii YJ. Characterization of H-Idbelled platelet activating factor receptor ccunplex sohihilized from rdbbit platelet membranes. Biochim BiophysActa 1988 970 103-112... 

Duronio V. Characterization of platelet-activating factor receptors in porcine platelets. Can J Physiol Pharmacol 1990 68 1514-1519... 

Nakamura M, Honda Z, Izumi T, Sakanaka C, Mutoh H, Minami M, Bito H, Seyama Y, Matsumoto T, Noma M, Shimizu T. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991 266 20400-20405... 

Rogers JE, Duronio V, Wong SI, McNeil M, Salari H. Solubilization of a functionally active platelet-activating factor receptor from rabbit platelets. Biochem J1991 278 405-410... 

Shukla SD. Platelet activating factor receptor and signal transduction mechanisms. FASEB 1992 6 2296-2301... 

Shukla SD, Thurston AW, Zhu CY, Dhar A. Platelet activating factor receptor functions via phosphoinositide turnover and tyrosine kinase in Platelet activating factor recqrtor Signal mechanisms and molecular biology. Edited by S. D. Shukla, CRC Press 1993 41-59... 

E6123 is a triazolothienodiazepine derivative, a ll,4)benzodiazepine, which has been developed as an experimental PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST. EA 1299 tenamfetamine. 

Modecate fluphenazine. modipafant [ban, inn] (UK 80067) is a complex heterocyclic, a PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST. Moditen fluphenazine. 

---